Hyperlipoproteinemia Type Ii
📧 Sign up to get email alerts when something new happens for Hyperlipoproteinemia Type Ii.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) [Phase 3]
Phase 3 trial assessing tolerability and efficacy of anacetrapib co-administered with statin in participants with heterozygous familial hype…
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042) [Phase 3]
Phase 3 trial evaluating the efficacy and tolerability of adding anacetrapib to ongoing lipid-lowering therapy in adults with Homozygous Fam…